Severe Refractory Hypocalcemia After Administering Zoledronic Acid for Osteoporotic Fracture in Primary Hyperparathyroidism That Is Complicated Into Hungry Bone Syndrome: A Case Report

Zoledronic acid is a very effective (IV) amino bisphosphonate which is indicated in osteoporosis, hypercalcemia of malignancy, multiple myeloma, Paget’s disease, and bone metastases from solid tumors. Bisphosphonate inhibits bone resorption through actions on osteoclast activity resulting in increas...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Endocr Soc
Asıl Yazarlar: Alhamdan, Ali Saleh, Douba, Najah Younes, Aljamaan, Abdulaziz, Alghamdi, Abdulrahman Aidh, Alhammad, Zahrah Abbas, Alanazi, Khalid
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2021
Konular:
Bone and Mineral Metabolism
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089785/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.450
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller